Acrivastine

CAS : 87848-99-5

Ref. 3D-FA31634

Informations sur le produit

• Nom: Acrivastine
• Marque: Biosynth
• Description: Acrivastine is a drug that belongs to the group of combination therapy. It is used in the treatment of autoimmune diseases, such as choroidal neovascularization. Acrivastine inhibits the production of prostaglandin E2 (PGE2) and inhibits the release of histamine from mast cells. Acrivastine also has immunosuppressive effects. It binds to H1 receptors and blocks their activation by histamine, which may be responsible for its therapeutic effect on eye disorders and infectious diseases. Acrivastine is chemically stable in acidic or alkaline conditions, but does not dissolve in organic solvents.

Propriétés chimiques

• Masse moléculaire: 348.44 g/mol
• Formule: C₂₂H₂₄N₂O₂
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder
• InChI: InChI=1S/C22H24N2O2/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26/h4-13H,2-3,14-16H2,1H3,(H,25,26)/b12-11+,20-13+
• Code InChI: InChIKey=PWACSDKDOHSSQD-IUTFFREVSA-N
• SMILES: Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1